Ethnic differences in the characteristics of patients with newly diagnosed lung cancer in the Te Manawa Taki region of New Zealand

被引:0
|
作者
Nguyen, Ha [1 ]
Lao, Chunhuan [1 ]
Keenan, Rawiri [1 ]
Laking, George [3 ,4 ]
Elwood, Mark [3 ]
McKeage, Mark [3 ,4 ]
Wong, Janice [2 ]
Aitken, Denise [5 ]
Chepulis, Lynne [1 ]
Lawrenson, Ross [1 ,2 ,6 ]
机构
[1] Univ Waikato, Med Res Ctr, Hamilton, New Zealand
[2] Te Whatu Ora Hlth New Zealand, Hamilton, New Zealand
[3] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand
[4] Te Whatu Ora Hlth New Zealand Te Toka Tumai, Auckland, New Zealand
[5] Te Whatu Ora Hlth New Zealand, Rotorua, New Zealand
[6] Univ Waikato, Med Res Ctr, Te Huataki Waiora Sch Hlth, Private Bag 3105, Hamilton 3240, New Zealand
关键词
lung cancer; Maori; inequity; cancer stage; ethnic differences; MAORI;
D O I
10.1111/imj.16202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMaori have three times the mortality from lung cancer compared with non-Maori. The Te Manawa Taki region has a population of 900 000, of whom 30% are Maori. We have little understanding of the factors associated with developing and diagnosing lung cancer and ethnic differences in these characteristics. AimsTo explore the differences in the incidence and characteristics of patients with newly diagnosed lung cancer between Maori and non-Maori. MethodsPatients were identified from the regional register. Incidence rates were calculated based on population data from the 2013 and 2018 censuses. The patient and tumour characteristics of Maori and non-Maori were compared. The analysis used X-2 tests and logistic models for categorical variables and Student t tests for continuous variables. ResultsA total of 4933 patients were included, with 1575 Maori and 3358 non-Maori. The age-standardised incidence of Maori (236 per 100 000) was 3.3 times higher than that of non-Maori. Maori were 1.3 times more likely to have an advanced stage of disease and 1.97 times more likely to have small cell lung cancer. Maori were more likely to have comorbidities, chronic obstructive pulmonary disease, cardiovascular disease and diabetes. They also had higher levels of social deprivation and tended to be younger, female and current smokers. ConclusionsThe findings point to the need to address barriers to early diagnosis and the need for system change including the need to introduce a lung cancer screening focussing on Maori. There is also the need for preventive programmes to address comorbidities that impact lung cancer outcomes as well as a continued emphasis on creating a smoke-free New Zealand.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [31] Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities
    Sanjeewa Seneviratne
    Ian Campbell
    Nina Scott
    Rachel Shirley
    Tamati Peni
    Ross Lawrenson
    Cancer Causes & Control, 2015, 26 : 1813 - 1824
  • [32] Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities
    Seneviratne, Sanjeewa
    Campbell, Ian
    Scott, Nina
    Shirley, Rachel
    Peni, Tamati
    Lawrenson, Ross
    CANCER CAUSES & CONTROL, 2015, 26 (12) : 1813 - 1824
  • [33] Te Oranga Pūkahukahu research programme: intentional steps towards a national equity-focused lung cancer screening programme in Aotearoa New Zealand
    Parker, Kate
    Bartholomew, Karen
    Sandiford, Peter
    Crengle, Sue
    JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND, 2025,
  • [34] Newly diagnosed type 2 diabetes - does New Zealand General Practice adequately prepare patients to self-manage their Condition?
    Chepulis, Lynne
    Mellsop-Kupe, Jessie
    Moorhouse, Suzanne
    Keenan, Rawiri
    Norman, Kimberley
    Paul, Ryan
    BMC PRIMARY CARE, 2023, 24 (01):
  • [35] The significance of social support and social networks among newly diagnosed lung cancer patients in Sweden
    Sjolander, Catarina
    Bertero, Carina
    NURSING & HEALTH SCIENCES, 2008, 10 (03) : 182 - 187
  • [36] Quality of Life and Related Factors in Patients With Newly Diagnosed Advanced Lung Cancer: A Longitudinal Study
    Liao, Yu-Chien
    Shun, Shiow-Ching
    Liao, Wei-Yu
    Yu, Chong-Jen
    Yang, Pan-Chyr
    Lai, Yeur-Hur
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E44 - E55
  • [37] Latent TB infection in newly diagnosed lung cancer patients - A multicenter prospective observational study
    Fan, Wen-Chien
    Ting, Wen-Ying
    Lee, Ming-Che
    Huang, Shiang-Fen
    Chiu, Chao-Hua
    Lai, Shinn-Liang
    Chen, Yuh-Min
    Shih, Jen-Fu
    Lin, Ching-Hsiung
    Kao, Shang-Jyh
    Wu, Ming-Fang
    Tsao, Thomas Chang Yao
    Wu, Chieh-Hung
    Yang, Kuang-Yao
    Lee, Yu-Chin
    Feng, Jia-Yih
    Su, Wei-Juin
    LUNG CANCER, 2014, 85 (03) : 472 - 478
  • [38] Disparities in clinical and demographic characteristics among Asian/Pacific Islander and Non-Hispanic White newly diagnosed lung cancer patients
    Parth B. Patel
    Naomi Alpert
    Emanuela Taioli
    Raja Flores
    Cancer Causes & Control, 2022, 33 : 547 - 557
  • [39] Variation in Comorbidity and Clinical Management in Patients Newly Diagnosed with Lung Cancer in Four Scottish Centers
    Grose, Derek
    Devereux, Graham
    Brown, Louise
    Jones, Richard
    Sharma, Dave
    Selby, Colin
    Morrison, David S.
    Docherty, Kirsty
    McIntosh, David
    Louden, Greig
    Downer, Penny
    Nicolson, Marianne
    Milroy, Robert
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : 500 - 509
  • [40] A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand
    Sanjeewa Seneviratne
    Ian Campbell
    Nina Scott
    Ross Lawrenson
    BMC Health Services Research, 17